Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).

The Middle Tennessee Chapter of the Juvenile Diabetes Research Foundation (JDRF) recently named Meg Rush, M.D., as the 2017 JDRF Living & Giving Honoree.

A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

Blood-forming stem cells play a role in immune tolerance and acceptance of organ transplants, Vanderbilt researchers have discovered.

Researchers at Vanderbilt University Medical Center have received more than $11 million in new grant support aimed at slowing the growing burden of diabetes.

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.